arginine has been researched along with Recrudescence in 91 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (12.09) | 18.7374 |
| 1990's | 34 (37.36) | 18.2507 |
| 2000's | 23 (25.27) | 29.6817 |
| 2010's | 20 (21.98) | 24.3611 |
| 2020's | 3 (3.30) | 2.80 |
| Authors | Studies |
|---|---|
| Campos-Rodríguez, C; Chávez-Reyes, J; Marichal-Cancino, BA; Miranda-Páez, A; Ramírez-San Juan, E; Vázquez-León, P | 1 |
| Barman-Aksözen, J; Huber, LC; Minder, E; Senn, JD | 1 |
| Atzler, D; Böger, RH; Choe, CU; Cordts, K; Gerloff, C; Grant, PJ; Grzybowski, R; Hornig, S; Lezius, S; Lüneburg, N; Magnus, T; Neu, A; Schwedhelm, E; Thomalla, G | 1 |
| Bosco-Garate, I; Ferat-Osorio, E; Juárez-Oropeza, MA; Martinez, JL; Méndez, JD; Román-Ramos, R; Souza-Gallardo, LM | 1 |
| Chen, KJ; Chen, Z; Gao, ZY; Shang, QH; Shi, DZ; Xu, H; Yu, CA | 1 |
| Hirayama, A; Kogawa, R; Mano, H; Nagashima, K; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Watanabe, I | 1 |
| Alasady, M; Chakrabarty, A; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD | 1 |
| Guan, X; Hussain, A; Liu, S; Liu, Y; Shi, B; Zhao, Y | 1 |
| Ran, X; Wang, DW; Zhang, Q | 1 |
| Arachchillage, DR; Baglin, T; Besser, M; Maclean, R; van Veen, JJ | 1 |
| Li, J; Qu, X; Song, Y; Xia, W; Yin, Z | 1 |
| Pelcastre, EL; Villanueva-Mendoza, C; Zenteno, JC | 1 |
| Brito, LP; Bronstein, MD; Fragoso, MC; Lerário, AM; Mendonca, BB; Soares, IC | 1 |
| Benedict, RH; Bistulfi, GL; Chadha, K; Hennies, C; Kazim, L; Leung, C; Munschauer, F; Sternberg, D; Sternberg, Z; Weinstock-Guttman, B | 1 |
| Arnesen, H; Bratseth, V; Seljeflot, I; Smith, P; Tveit, A | 1 |
| Dechun, Y; Shuqin, S; Wei, F; Xiufen, Q; Yang, L; Yang, Y; Yanwei, Y; Ying, S | 1 |
| Chafetz, D; Maric, T; Schoela, N; Sedki, F; Shalev, U | 1 |
| Mhanni, AA; Prasad, C; Rockman-Greenberg, C | 1 |
| Dugas, TR; Foley, JD; Hebert, VY; Kleinedler, JJ; Orchard, EA; Rogers, LK | 1 |
| Böger, R; Breitling, LP; Brenner, H; Koenig, W; Maas, R; Rothenbacher, D; Schwedhelm, E; Siegerink, B; Vossen, CY | 1 |
| Bay, C; Bentz, S; Memari, S; Nowroozi, S; Sharifi, M; Valeros, G | 1 |
| Andersson, C; Bäckström, T; Nilsson, A | 1 |
| Franke, J; Gasslander, T; Sandstrom, P; Sundqvist, T; Svanvik, J | 1 |
| Abbott, RL; Crawford, JB; Margolis, TP; Spencer, WH; Warren, JF; Yoon, MK | 1 |
| Ishiko, A; Masunaga, T; Murata, T; Nishikawa, T; Shimizu, H | 1 |
| Ittmann, M; Stockton, DW; Wang, J | 1 |
| Böger, RH; Kähler, J; Krempl, TK; Maas, R; Meinertz, T; Sydow, K | 1 |
| Chen, CJ; Chen, CM; Chen, IC; Lee-Chen, GJ; Lin, CY; Ro, LS; Wu, YR | 1 |
| Katz, E; Kim, KY; McNulty, I | 1 |
| Aghababian, RV; Begelman, SM; Hursting, MJ; McCollum, D | 1 |
| Fujita, S; Itonaga, T; Masumoto, H; Nakai, M; Nomura, R; Shimamoto, M; Yamazaki, F | 1 |
| De Carlo, E; degli Uberti, EC; Fallo, F; Pilon, C; Zatelli, MC | 1 |
| Beer, R; Kdolsky, R; Reihsner, R | 1 |
| McCune, MA; Muller, SA; O'Fallon, WM; Perry, HO | 1 |
| Hurt, WC; Thein, DJ | 1 |
| Ambrogi, F; Azzarà, A; Carulli, G; Minnucci, S; Natale, M; Rizzuti-Gullaci, A; Sbrana, S | 1 |
| Mehta, JL; Yang, BC | 2 |
| Akhtar, S; Buja, LM; Casscells, W; Golino, P; Ober, JC; Scott-Burden, T; Willerson, JT; Yao, SK | 1 |
| Bättig, U; Cakmakci, M; Geroulanos, S; Schilling, J | 1 |
| Abe, H; Okabe, H; Okajima, K; Takatsuki, K; Wagatsuma, M | 1 |
| Berends, F; Büller, H; Koopman, R; Mertens, K; Roelse, J; ten Cate, JW; van Mourik, JA; Voorberg, J | 1 |
| Herrman, JP; Serruys, PW | 1 |
| Baudry, P; Callebert, J; Deybach, JC; Nordmann, Y; Puy, H; Touitou, Y | 1 |
| Garabedian, HD; Gold, HK; Hagstrom, JN; Jang, IK; Khan, A; Leinbach, RC; Newell, JB; Torres, FW; Werner, W; Yasuda, T | 1 |
| Casscells, W; Willerson, JT | 1 |
| Bignell, P; Cooper, DN; Grundy, CB; Kakkar, VV; Martin, R; Millar, DS; Moffat, EH | 1 |
| Figliuzzi, M; Gaspari, F; Macconi, D; Noris, M; Paris, S; Remuzzi, G; Ruggenenti, P; Todeschini, M; Zoja, C | 1 |
| Alving, BM; Carrington, LR; Gillespie, DL; Griffin, JH | 1 |
| Herlitz, H; Petersson, A; Sigström, L; Wennmalm, A; Westberg, G | 1 |
| Fareed, J; Lewis, BE; Rangel, Y | 1 |
| Bauters, C; Bertrand, ME; Lablanche, JM; Meurice, T; Van Belle, E | 1 |
| Kawatani, A; Kobayashi, A; Kurosawa, Y; Miki, S; Mizoguchi, T; Murata, S; Nakajima, H; Sakurai, T; Takeuchi, T; Yoshida, A | 1 |
| Ambrosioni, G; Baligan, M; Giardina, A; Giovannini, G; Laghi, MG | 1 |
| Hirayama, F; Kawasaki, T; Koshio, H; Matsumoto, Y; Sato, K; Taniuchi, Y | 1 |
| Bolton, LL; Cackovic, M; Chung, C; Kerstein, MD | 1 |
| Anderson, HV; Bazzino, O; Brown, DF; Dinsmore, R; Dutra, OP; Giugliano, RP; Jang, IK; Liprandi, AS; Losordo, D; Massey, TJ; Nicolau, JC; Norbady, R; Schwarz, RP; Viamonte, VM | 1 |
| Elgün, S; Gökhun, IH; Güney, K; Tuncer, M | 1 |
| Alfke, H; Barry, JJ; Bergen, S; Kalinowski, M; Klose, KJ; Wagner, HJ | 1 |
| Lee, SC; Yoo, JH | 1 |
| Charlton, B; Cowden, WB; O'Brien, NC; Willenborg, DO | 1 |
| Beck, M; Dertinger, S; Drexel, H; Lohse, P; Ruebsamen, H; Tautermann, G | 1 |
| Cooper, DN; Grundy, CB; Kakkar, VV; Schulman, S; Tengborn, L | 1 |
| Collen, D; Fallon, JT; Gold, HK; Guerrero, JL; Holt, R; Jang, IK; Leinbach, RC; Yaoita, H; Yasuda, T | 1 |
| Chesebro, JH; Fuster, V | 1 |
| Bush, LR; Connolly, TM; Mellott, MJ; York, SJ | 1 |
| Cook, A; Goldberg, A; Herrick, AL; McColl, KE; Moore, MR | 1 |
| Archer, R; Hollingsworth, DR | 1 |
| Imler, M; Kurtz, D; Peter, B; Ruscher, H; Stahl, J | 1 |
| Cheng, HY; Li, TT; Wang, JB; Wang, WJ; Yang, F; Yang, YX; Zhang, YF | 1 |
| Arcari, A; Centurioni, R; Evangelista, A; Freilone, R; Ladetto, M; Liberati, AM; Luminari, S; Massidda, S; Merli, F; Musuraca, G; Nassi, L; Patti, C; Pavone, V; Peli, A; Pulsoni, A; Re, A; Salvi, F; Spina, M; Stelitano, C; Tani, M; Tucci, A; Volpetti, S; Zanni, M | 1 |
| Hobeika, L; Self, SE; Velez, JC | 1 |
| Bratengeier, K; Flentje, M; Kölbl, O; Ruprecht, K; Vince, GH; Vordermark, D | 1 |
| Selleslag, D | 1 |
| Burgers, JM; Dekker, AW; Kazem, I; Kroese, WF; Qasim, MM; Sizoo, W; Somers, R; van Peperzeel, HA; Wagener, DJ | 1 |
| Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Kalwinsky, DK; Murphy, SB; Rivera, G; Stagner, S; Wood, A | 1 |
| Aur, RJ; Avery, TL; Dahl, GV; Pratt, CB; Rivera, G; Wood, A | 1 |
| Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
| Chan, LC; Chan, TK; Chiu, EK; Kwong, YL; Liang, R; Lie, A; Todd, D | 1 |
| Gerrits, WB; Haak, HL; Kerkhofs, H; Wijermans, PW | 1 |
| Buchanan, GR; Rivera, GK; Sadowitz, PD; Shuster, J; Smith, SD; Wharam, MD | 1 |
| Boyett, JM; Buchanan, GR; Chauvenet, AR; Crist, WM; Maybee, DA; Pinkel, D; Pollock, BH; Rivera, GK; Wagner, H | 1 |
| André, F; Bayssas, M; Caillot, D; Canal, P; Casasnovas, RO; Chauffert, B; Fenaux, P; Genne, P; Grandjean, M; Guy, H; Mannone, L; Moreau, D; Solary, E; Wolf, JE; Wotawa, A | 1 |
| Bibeau, F; Cebotaru, C; El Weshi, A; Fadel, C; Fenaux, P; Frayfer, J; Laribi, K; Ribrag, V | 1 |
| Pavone-Macaluso, M | 1 |
| Mechl, Z; Rovný, F; Sopková, B | 1 |
| Gadner, H; Harbott, J; Henze, G; Lampert, F; Ludwig, WD; Müller-Weihrich, S; Niemeyer, CM; Reiter, A; Ritter, J; Schrappe, M | 1 |
| Abromowitch, M; Harris, M; Kavanagh, R; Ochs, J; Rivera, GK; Rodman, J; Yalowich, J | 1 |
| Boyett, JM; Buchanan, GR; Crist, WM; Ghim, T; Johnson, W; Pollock, BH; Smith, SD; Vietti, TJ; Wharam, MD; Yanofsky, RA | 1 |
| Belasco, JB; Luery, N; Scher, C | 1 |
| Bezanilla Regato, JL; Moya Calderón, E; Navajas Gutiérrez, A; Piñán, MA | 1 |
3 review(s) available for arginine and Recrudescence
| Article | Year |
|---|---|
[CME: Acute Intermittent Porphyria: When to Think of It? What Must be Checked? How to Treat?]
Topics: Arginine; Combined Modality Therapy; Diagnosis, Differential; Female; Genetic Predisposition to Disease; Heme; Hemin; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Middle Aged; Porphobilinogen; Porphyria, Acute Intermittent; Prognosis; Recurrence; Risk Factors | 2018 |
Thrombin and antithrombotic therapy in interventional cardiology.
Topics: Angioplasty, Balloon, Coronary; Animals; Antithrombins; Arginine; Coronary Disease; Fibrinolytic Agents; Heparin; Hirudin Therapy; Humans; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombin | 1994 |
[Endothelial dysfunction in cardiovascular diseases: therapeutic implications after coronary angioplasty].
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Endothelium, Vascular; Growth Substances; Humans; Hyperplasia; Nitric Oxide; Recurrence; Tunica Intima | 1997 |
18 trial(s) available for arginine and Recrudescence
| Article | Year |
|---|---|
Effect of Preoperative Administration of Oral Arginine and Glutamine in Patients with Enterocutaneous Fistula Submitted to Definitive Surgery: a Prospective Randomized Trial.
Topics: Administration, Oral; Adult; Arginine; C-Reactive Protein; Cutaneous Fistula; Dietary Supplements; Digestive System Surgical Procedures; Female; Glutamine; Humans; Interleukin-6; Intestinal Fistula; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Postoperative Period; Preoperative Care; Prospective Studies; Recurrence | 2020 |
Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion.
Topics: Aged; Arginine; Atrial Fibrillation; Electric Countershock; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Recurrence; Rosuvastatin Calcium; Sulfonamides | 2009 |
L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Combined Modality Therapy; Double-Blind Method; Electric Countershock; Female; Humans; Male; Middle Aged; Recurrence; Tetrazoles; Time Factors | 2010 |
Thrombocytopenia following heparin flush.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Catheters, Indwelling; Cause of Death; Diagnosis, Differential; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Patient Selection; Pipecolic Acids; Platelet Count; Prospective Studies; Recurrence; Sulfonamides; Therapeutic Irrigation; Thrombocytopenia; Thrombosis; Treatment Outcome | 2005 |
Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride.
Topics: Administration, Oral; Arginine; Clinical Trials as Topic; Double-Blind Method; Electrolytes; Herpes Simplex; Humans; Lysine; Prospective Studies; Random Allocation; Recurrence | 1984 |
Effects of lysine-arginine association on immune functions in patients with recurrent infections.
Topics: Adult; Anti-Infective Agents; Arginine; Cell Movement; Chemotaxis, Leukocyte; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Humans; Immunity; Immunoglobulins; Immunophenotyping; Infections; Luminescent Measurements; Lymphocyte Subsets; Lysine; Male; Middle Aged; Neutrophils; Recurrence | 1995 |
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Topics: Aged; Angina, Unstable; Antithrombin III; Antithrombins; Arginine; Blood Coagulation; Drug Administration Schedule; Female; Fibrinopeptide A; Humans; Infusions, Intravenous; Male; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombin; Treatment Outcome | 1993 |
Clinical evaluation of the efficacy of an antithrombin agent "Argatroban" combined with exercise therapy on increase of the skeletal muscle blood flow.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Arteriosclerosis Obliterans; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Exercise Therapy; Humans; Male; Muscle, Skeletal; Pipecolic Acids; Prostaglandins E; Recurrence; Regional Blood Flow; Skin Temperature; Sulfonamides; Vasodilator Agents | 1996 |
[L-arginine and immunity. Study of pediatric subjects].
Topics: Adolescent; Arginine; Child; Child, Preschool; Female; Humans; Immunity, Innate; Male; Nitric Oxide; Recurrence; Respiratory Tract Infections; Treatment Outcome | 1997 |
A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
Topics: Adult; Arginine; Chemotherapy, Adjuvant; Coronary Angiography; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Recurrence; Single-Blind Method; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 1999 |
Controlled trial of haem arginate in acute hepatic porphyria.
Topics: Acute Disease; Adolescent; Arginine; Clinical Trials as Topic; Double-Blind Method; Female; Heme; Heroin; Humans; Infusions, Intravenous; Injections, Intravenous; Liver Diseases; Male; Meperidine; Pain; Phlebitis; Porphyrias; Random Allocation; Recurrence; Severity of Illness Index | 1989 |
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Carmustine; Combined Modality Therapy; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prognosis; Recurrence; Remission Induction; Survival Analysis; Teniposide; Treatment Outcome | 2019 |
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Recurrence; Teniposide; Vincristine | 1993 |
Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Cytarabine; Female; Humans; Leukocyte Count; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Teniposide; Time Factors; Treatment Failure | 1993 |
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine | 2000 |
Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cinchona Alkaloids; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrocardiography; Female; Heart; Humans; Leukopenia; Lymphoproliferative Disorders; Male; Middle Aged; Prednisone; Recurrence; Teniposide | 2000 |
A phase II study of combined methotrexate and teniposide infusions prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Evaluation; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Teniposide | 1991 |
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Survival Rate; Teniposide; Testicular Neoplasms; Vincristine | 1991 |
70 other study(ies) available for arginine and Recrudescence
| Article | Year |
|---|---|
NPY-Y
Topics: Alcohol Drinking; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Ethanol; Male; Maze Learning; Microinjections; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Recurrence | 2020 |
Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA
Topics: Aged; Arginine; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cross-Sectional Studies; Female; Homoarginine; Humans; Intracranial Hemorrhages; Male; Middle Aged; Recurrence; Stroke | 2019 |
Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease.
Topics: Arginine; Biomarkers; Coronary Disease; Humans; Odds Ratio; Recurrence; Risk Factors; ROC Curve; Syndrome | 2019 |
Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation.
Topics: Adiponectin; Arginine; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Catheter Ablation; Diagnostic Imaging; Echocardiography; Electrocardiography; Extracellular Matrix; Female; Humans; Inflammation; Interleukin-6; Male; Matrix Metalloproteinase 2; Middle Aged; Predictive Value of Tests; Recurrence; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Treatment Outcome | 2014 |
Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Activation; Prospective Studies; Recurrence; Stroke | 2014 |
The efficacy of percutaneous AHI (arginine hydrochloride injection) for the treatment of recurrent thyroid cysts.
Topics: Adult; Arginine; Cysts; Female; Follow-Up Studies; Humans; Injections, Intralesional; Injections, Subcutaneous; Male; Middle Aged; Recurrence; Sclerotherapy; Suction; Thyroid Nodule; Treatment Outcome; Ultrasonography | 2015 |
Tissue Kallikrein Activity, Detected by a Novel Method, May Be a Predictor of Recurrent Stroke: A Case-Control Study.
Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Female; Humans; Male; Middle Aged; Recurrence; Stroke; Tissue Kallikreins; Urinalysis | 2015 |
Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Factor Xa Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Neoplasms; Pipecolic Acids; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Sulfonamides; Venous Thrombosis | 2016 |
Novel and recurrent NDP gene mutations in familial cases of Norrie disease and X-linked exudative vitreoretinopathy.
Topics: Adult; Arginine; Base Sequence; Child, Preschool; Exudates and Transudates; Eye Diseases; Eye Proteins; Genes, X-Linked; Haplotypes; Humans; Infant, Newborn; Male; Mutation, Missense; Nerve Tissue Proteins; Pedigree; Rare Diseases; Recurrence; Retinal Diseases; Threonine; Ultrasonography; Vitreous Body; Young Adult | 2010 |
Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing's disease outcome.
Topics: ACTH-Secreting Pituitary Adenoma; Adolescent; Adult; Amino Acid Substitution; Arginine; Child; Female; Gene Expression; Glycine; Humans; Hypophysectomy; Male; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Polymorphism, Single Nucleotide; Prognosis; Receptor, Fibroblast Growth Factor, Type 4; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Plasma pentosidine: a potential biomarker in the management of multiple sclerosis.
Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Inflammation Mediators; Linear Models; Lysine; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; New York; Predictive Value of Tests; Recurrence; Severity of Illness Index; Spectrometry, Fluorescence; Time Factors; Treatment Outcome; Up-Regulation | 2011 |
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; Body Surface Potential Mapping; Catheter Ablation; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Risk Assessment; Survival Rate; Time Factors; Treatment Outcome | 2011 |
A role for neuropeptide Y Y5 but not the Y1-receptor subtype in food deprivation-induced reinstatement of heroin seeking in the rat.
Topics: Animals; Arginine; Behavior, Animal; Benzothiepins; Dose-Response Relationship, Drug; Food Deprivation; Heroin; Male; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Recurrence; Self Administration; Sulfonamides | 2011 |
Ornithine transcarbamylase deficiency presenting as recurrent abdominal pain in childhood.
Topics: Abdominal Pain; Alkalosis, Respiratory; Arginine; Carbamoyl-Phosphate Synthase I Deficiency Disease; Child, Preschool; Citrulline; Consciousness Disorders; Diagnosis, Differential; Diet, Protein-Restricted; Emergencies; Exons; Female; Glutamine; Humans; Hyperammonemia; Language Development Disorders; Liver Transplantation; Mutation, Missense; Ornithine Carbamoyltransferase; Ornithine Carbamoyltransferase Deficiency Disease; Phenylbutyrates; Recurrence | 2011 |
A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting.
Topics: Angioplasty, Balloon; Animals; Arginine; Biomarkers; Carotid Arteries; Carotid Artery Injuries; Carotid Stenosis; Choline Deficiency; Diet, Atherogenic; Disease Models, Animal; Endothelial Cells; Female; Hyperplasia; Inflammation Mediators; Interleukin-6; Lipids; Male; Platelet Activation; Rats; Rats, Sprague-Dawley; Recurrence; Reproducibility of Results; Stents; Thromboxane B2; Time Factors; Ultrasonography, Doppler, Color | 2011 |
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Topics: Aged; Arginine; Biomarkers; Cause of Death; Chromatography, Liquid; Coronary Disease; Female; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Tandem Mass Spectrometry; Time Factors | 2013 |
Catheter-directed thrombolysis with argatroban and tPA for massive iliac and femoropopliteal vein thrombosis.
Topics: Arginine; Catheterization, Peripheral; Catheters; Drug Therapy, Combination; Female; Femoral Vein; Fibrinolytic Agents; Follow-Up Studies; Humans; Iliac Vein; Male; Middle Aged; Phlebography; Pipecolic Acids; Platelet Aggregation Inhibitors; Popliteal Vein; Recurrence; Severity of Illness Index; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2013 |
Atypical attack of acute intermittent porphyria--paresis but no abdominal pain.
Topics: Abdominal Pain; Adult; Arginine; Disease Progression; Estradiol; Female; Heme; Humans; Hysterectomy; Middle Aged; Ovariectomy; Paresis; Periodicity; Porphyria, Acute Intermittent; Progesterone; Recurrence | 2002 |
Depletion of serum L-arginine in patients with acute pancreatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Alcoholism; Amylases; Arginine; C-Reactive Protein; Cholecystitis, Acute; Citrulline; Female; Gallstones; Humans; Male; Middle Aged; Nitrates; Nitrites; Pancreatitis; Pancreatitis, Alcoholic; Recurrence; Time Factors | 2003 |
A new mutation (Leu569Arg) within exon 13 of the TGFBI (BIGH3) gene causes lattice corneal dystrophy type I.
Topics: Adult; Amino Acid Substitution; Arginine; Child, Preschool; Corneal Dystrophies, Hereditary; DNA Mutational Analysis; Exons; Extracellular Matrix Proteins; Female; Humans; Keratoplasty, Penetrating; Leucine; Male; Pedigree; Point Mutation; Polymerase Chain Reaction; Recurrence; Reoperation; Sequence Analysis, DNA; Transforming Growth Factor beta; Visual Acuity | 2003 |
Differences in recurrent COL7A1 mutations in dystrophic epidermolysis bullosa: ethnic-specific and worldwide recurrent mutations.
Topics: Alanine; Arginine; Asian People; Collagen Type VII; Cysteine; Epidermolysis Bullosa Dystrophica; Gene Deletion; Gene Frequency; Global Health; Glutamic Acid; Glycine; Humans; Japan; Mutation; Recurrence; United Kingdom | 2004 |
The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
Topics: Alleles; Arginine; Case-Control Studies; Cell Movement; Collagen; Disease Progression; DNA; DNA, Complementary; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Genotype; Glycine; Homozygote; Humans; Immunohistochemistry; Laminin; Male; Neoplasm Metastasis; Polymorphism, Genetic; Prostatic Neoplasms; Proteoglycans; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Cell Surface; Receptors, Fibroblast Growth Factor; Receptors, Urokinase Plasminogen Activator; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection; Up-Regulation; Wound Healing | 2004 |
Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Arginine; Case-Control Studies; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors | 2005 |
Recurrent cerebral venous thrombosis: an Arg359X mutation in the antithrombin gene in a Taiwanese family.
Topics: Antithrombins; Arginine; Family; Female; Humans; Intracranial Thrombosis; Male; Pedigree; Phlebography; Point Mutation; Recurrence; Taiwan | 2006 |
Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Drug Administration Schedule; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome; Warfarin | 2005 |
A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Leg; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombectomy; Thrombocytopenia; Thromboembolism | 2007 |
Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation?
Topics: Adenoma; Amino Acid Substitution; Arginine; Female; Glutamine; Humans; Hyperparathyroidism, Primary; Middle Aged; Mutation; Parathyroid Neoplasms; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins; Recurrence | 2008 |
Biomechanical analysis of fracture healing in guinea-pigs.
Topics: Administration, Oral; Animals; Arginine; Biomechanical Phenomena; Femur; Fracture Healing; Fractures, Bone; Guinea Pigs; Male; Models, Animal; Recurrence; Risk Factors; Stress, Mechanical | 2008 |
Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis.
Topics: Adolescent; Adult; Arginine; Child; Diet; Double-Blind Method; Female; Herpes Labialis; Humans; Lysine; Male; Middle Aged; Recurrence; Time Factors | 1984 |
Alterations in pulmonary artery tone during repeated episodes of hypoxia.
Topics: Animals; Arginine; Hypoxia; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxyhemoglobins; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Recurrence; Vasoconstriction; Vasomotor System | 1995 |
Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis.
Topics: Animals; Arginine; Coronary Circulation; Coronary Thrombosis; Dogs; Electric Stimulation; Hematocrit; Nitric Oxide; Nitrites; Nitroarginine; Nitroprusside; Platelet Aggregation; Recurrence; Thrombolytic Therapy; Whole Blood Coagulation Time | 1995 |
A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Blood Pressure; Cardiac Output; Combined Modality Therapy; Critical Care; Dose-Response Relationship, Drug; Humans; Hypotension; Male; Necrosis; Nitric Oxide Synthase; omega-N-Methylarginine; Pancreatitis; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Shock, Septic; Staphylococcal Infections | 1993 |
Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
Topics: Adult; Antithrombin III; Arginine; Base Sequence; Chromatography, Affinity; Factor X; Female; Heparin; Histidine; Humans; Immunoelectrophoresis, Two-Dimensional; Molecular Sequence Data; Mutation; Pedigree; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Recurrence; Thrombin; Thrombophlebitis | 1995 |
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.
Topics: Adult; Aged; Arginine; Base Composition; Base Sequence; DNA Primers; Factor V; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Point Mutation; Protein C; Recurrence; Thromboembolism | 1994 |
Prior episode of anoxia attenuates vasorelaxation in response to subsequent episode of anoxia.
Topics: Adenosine; Animals; Aorta; Arginine; Calcium; Endothelium, Vascular; Free Radicals; Hypoxia; In Vitro Techniques; Nitric Oxide; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Purinergic P1 Receptor Antagonists; Rats; Recurrence; Vasodilation | 1994 |
Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks.
Topics: Adult; Arginine; Circadian Rhythm; Female; Heme; Humans; Melatonin; Porphyria, Acute Intermittent; Recurrence; Tryptophan | 1993 |
Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal?
Topics: Angina, Unstable; Antithrombin III; Antithrombins; Arginine; Humans; Pipecolic Acids; Recurrence; Sulfonamides; Thrombin | 1993 |
A Gla domain mutation (Arg 15-->Trp) in the protein C (PROC) gene causing type 2 protein C deficiency and recurrent venous thrombosis.
Topics: 1-Carboxyglutamic Acid; Arginine; Base Sequence; Conserved Sequence; Humans; Molecular Sequence Data; Mutation; Pedigree; Protein C; Protein C Deficiency; Recurrence; Thrombosis; Tryptophan | 1993 |
Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Adolescent; Adult; Arginine; Cells, Cultured; Chromatography, High Pressure Liquid; Endothelium, Vascular; Female; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Neutrophils; Nitrates; Nitric Oxide; Nitrites; Purpura, Thrombotic Thrombocytopenic; Recurrence; Superoxides; Thrombosis; Tumor Necrosis Factor-alpha | 1996 |
Resistance to activated protein C: a common inherited cause of venous thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Antithrombin III; Arginine; Contraceptives, Oral; DNA; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Mutation; Obesity; Pregnancy; Protein C; Protein C Deficiency; Protein S Deficiency; Recurrence; Risk Factors; Thromboembolism; Thrombophlebitis | 1996 |
The arginine-nitric oxide pathway in thrombotic microangiopathy.
Topics: Adult; Aged; Arginine; Child, Preschool; Enzyme Inhibitors; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Plasma; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Recurrence | 1997 |
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Carotid Arteries; Carotid Stenosis; Catheterization; Cerebrovascular Disorders; Femoral Artery; Follow-Up Studies; Heparin; Humans; Male; Paresis; Pipecolic Acids; Platelet Aggregation Inhibitors; Recurrence; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1998 |
Effect of a synthetic factor Xa inhibitor, YM-60828, on blood vessel patency in combination with a thrombolytic agent and on blood loss from the operation site in a rat model of arterial thrombosis.
Topics: Animals; Anticoagulants; Arginine; Blood Loss, Surgical; Carotid Arteries; Carotid Artery Thrombosis; Drug Evaluation, Preclinical; Hemorrhage; Heparin; Male; Naphthalenes; Pipecolic Acids; Piperidines; Rats; Recurrence; Reperfusion; Serine Proteinase Inhibitors; Sulfonamides; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 1998 |
Leg ulceration in the sickle cell patient.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Bandages, Hydrocolloid; Butyrates; Colloids; Combined Modality Therapy; Cost-Benefit Analysis; Erythropoietin; Female; Hospital Costs; Humans; Leg Ulcer; Length of Stay; Male; Occlusive Dressings; Recombinant Proteins; Recurrence; Retrospective Studies; Wound Healing | 1998 |
A potential role for arginase in recurrent infections and hypertrophy of tonsillar and adenoidal tissue.
Topics: Adenoids; Adolescent; Arginase; Arginine; Child; Female; Humans; Hypertrophy; Male; Palatine Tonsil; Recurrence; Tonsillitis | 2000 |
Comparative trial of local pharmacotherapy with L-arginine, r-hirudin, and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries.
Topics: Administration, Topical; Angioplasty, Balloon; Animals; Antithrombins; Arginine; Constriction, Pathologic; Hirudin Therapy; Hirudins; Iliac Artery; Male; Molsidomine; Nitric Oxide Donors; Rabbits; Recurrence; Vasodilator Agents | 2001 |
Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Topics: Aged; Aged, 80 and over; Arginine; Cerebral Infarction; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Homocysteine; Humans; Logistic Models; Male; Nitric Oxide Synthase; Recurrence; Risk Factors; Stroke | 2001 |
Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease.
Topics: Animals; Arginine; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Kinetics; Lymph Nodes; Lymphocyte Activation; Macrophages; Myelin Basic Protein; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Inbred Lew; Reactive Nitrogen Species; Recurrence; Spinal Cord | 2001 |
R116C mutation of cationic trypsinogen in a Turkish family with recurrent pancreatitis illustrates genetic microheterogeneity of hereditary pancreatitis.
Topics: Adult; Arginine; Chronic Disease; Cysteine; Exons; Germany; Humans; Male; Pancreatitis; Point Mutation; Polymerase Chain Reaction; Recurrence; Sequence Analysis, DNA; Trypsinogen; Turkey | 2001 |
Two different missense mutations at Arg 178 of the protein C (PROC) gene causing recurrent venous thrombosis.
Topics: Arginine; Base Sequence; Exons; Female; Heterozygote; Humans; Male; Molecular Sequence Data; Mutation; Pedigree; Protein C; Protein C Deficiency; Recurrence; Thrombophlebitis | 1992 |
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Arginine; Aspirin; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1990 |
Reperfusion, specific thrombin inhibition and reocclusion after thrombolysis.
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Arginine; Coronary Disease; Coronary Thrombosis; Dogs; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
Prevention of reocclusion by MCI-9038, a thrombin inhibitor, following t-PA-induced thrombolysis in a canine model of femoral arterial thrombosis.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Disease Models, Animal; Dogs; Femoral Artery; Hemodynamics; Male; Pipecolic Acids; Recurrence; Regional Blood Flow; Sulfonamides; Thrombin; Thrombin Time; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1990 |
Massive virginal breast hypertrophy at puberty.
Topics: Adolescent; Arginine; Breast; Breast Diseases; Craniocerebral Trauma; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hypertrophy; Hypothyroidism; Luteinizing Hormone; Mastectomy; Prostheses and Implants; Puberty; Recurrence; Thyroid Function Tests; Thyrotropin | 1973 |
[Action of arginine in a recurrent hepatic coma complicating a feminizing tumor of the adrenal cortex with hepatic metastases].
Topics: Adolescent; Adrenal Gland Neoplasms; Ammonia; Arginine; Estrogens; Feminization; Hepatic Encephalopathy; Humans; Liver; Liver Neoplasms; Male; Metabolic Diseases; Neoplasm Metastasis; Recurrence | 1973 |
Teniposide-intensified hematopoietic stem cell transplantation with acute graft versus host disease prophylaxis with anti-thymocyte globulin provides good results in high-risk or refractory recurrent hematopoietic malignant diseases.
Topics: Antilymphocyte Serum; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Recurrence; Retrospective Studies; Teniposide | 2021 |
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
Topics: Acute Kidney Injury; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Edema; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Hypertension, Renal; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Oligopeptides; Podocytes; Proteasome Inhibitors; Proteinuria; Pyrazines; Recurrence; Shock, Septic; Teniposide; Thalidomide; Thrombotic Microangiopathies | 2014 |
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Topics: Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Nimustine; Prognosis; Radiosurgery; Radiotherapy; Recurrence; Stereotaxic Techniques; Teniposide; Time Factors; Treatment Outcome | 2005 |
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Europe; Female; Hodgkin Disease; Humans; Leukopenia; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Radiotherapy; Recurrence; Teniposide; Vincristine | 1983 |
VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Podophyllotoxin; Prednisone; Recurrence; Teniposide; Vincristine | 1982 |
Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
Topics: Adolescent; Adult; Bone Marrow; Child; Child, Preschool; Cytarabine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hypotension; Leukemia, Lymphoid; Male; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide | 1980 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leucovorin; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1994 |
Primary breast lymphoma: a report of 20 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Middle Aged; Prednisone; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2001 |
Chemotherapy of bladder tumours.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Papilloma; Recurrence; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1978 |
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Topics: Carcinoma, Papillary; Humans; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide; Time Factors; Urinary Bladder Neoplasms | 1977 |
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Methotrexate; Prednisone; Prognosis; Recurrence; Remission Induction; Teniposide; Vincristine | 1992 |
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Hydrocortisone; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine | 1990 |
[Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Topics: Child; Child, Preschool; Cytarabine; Drug Combinations; Female; Humans; Male; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Risk Factors; Teniposide | 1988 |